GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $3.98 $5.74 Thursday, 18th Apr 2024 VTGN stock ended at $4.70. This is 0.642% more than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 4.78% from a day low at $4.60 to a day high of $4.82.
90 days $3.91 $5.74
52 weeks $1.62 $24.71

Historical VistaGen Therapeutics Inc prices

Date Open High Low Close Volume
2022-09-14 $5.70 $7.50 $5.70 $5.70 1 043 417
2022-09-13 $6.00 $6.00 $5.70 $5.70 258 700
2022-09-12 $6.00 $6.60 $5.70 $6.30 217 307
2022-09-09 $5.70 $6.60 $5.40 $6.30 503 843
2022-09-08 $5.10 $7.20 $5.10 $6.00 2 225 480
2022-09-07 $5.10 $5.10 $4.80 $5.10 206 793
2022-09-06 $5.40 $5.40 $4.80 $5.10 135 537
2022-09-02 $5.10 $5.40 $5.10 $5.40 165 693
2022-09-01 $5.10 $5.40 $4.80 $5.10 252 317
2022-08-31 $5.40 $5.70 $5.10 $5.40 183 323
2022-08-30 $5.40 $5.70 $5.10 $5.10 259 803
2022-08-29 $5.70 $5.70 $5.40 $5.70 248 027
2022-08-26 $6.00 $6.30 $5.70 $5.70 267 660
2022-08-25 $6.00 $6.60 $6.00 $6.30 328 183
2022-08-24 $6.00 $6.60 $5.70 $6.30 464 603
2022-08-23 $5.70 $6.30 $5.40 $6.00 393 353
2022-08-22 $5.70 $6.00 $5.40 $5.70 429 253
2022-08-19 $6.90 $7.20 $5.70 $6.60 1 680 870
2022-08-18 $5.40 $6.90 $5.10 $6.60 1 204 613
2022-08-17 $4.80 $6.00 $4.50 $5.70 822 210
2022-08-16 $4.80 $4.80 $4.80 $4.80 264 300
2022-08-15 $4.80 $4.80 $4.50 $4.80 340 747
2022-08-12 $5.10 $5.10 $4.50 $4.80 690 630
2022-08-11 $5.10 $5.70 $5.10 $5.40 759 730
2022-08-10 $4.80 $5.10 $4.80 $5.10 501 590
Click to get the best stock tips daily for free!

About VistaGen Therapeutics Inc

VistaGen Therapeutics VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III development for the acute treatment of anxiety in adults with social anxiety disorder. Its PH94B product... VTGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT